ClearStream enlists SMMD (Shanghai Micro Medical Devices) to break into Chinese market:
This article was originally published in Clinica
Irish catheter and stent specialist ClearStream Technologies has forged a distribution deal with Shanghai Micro Medical Devices (SMMD), in a move to penetrate the Chinese peripheral vascular market. SMMD is scheduled to begin distribution of ClearStream's peripheral angioplasty devices in early 2008, once product registration has been completed. Among the products to be sold by SMMD is ClearStream's ReeKross catheter for treating critical limb ischaemia. It is estimated that 10% of China's 41 million medically-insured retirees suffer from the condition, which can often result in amputation of the lower limbs due to lack of circulation in that area.
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.